SS
COEPW

Steve Schonfeld’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Steve Schonfeld’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,806
Closed -$1.08K – 2172
2022
Q4 		$1.08K Buy
+10,806
New +$722 ﹤0.01% 2459
2022
Q3 		– Sell
-11,406
Closed -$1K – 2984
2022
Q2 		$1K Buy
+11,406
New +$857 ﹤0.01% 2432

Other funds holding COEPW

ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Steve Schonfeld's COEPW Position: Q1 2023 in Review

Steve Schonfeld sold out of Coeptis Therapeutics Warrants (COEPW) in Q1 2023, closing a stake of 10,806 shares — an estimated $1.08K sold.

Steve Schonfeld first reported a position in COEPW in Q2 2022 and held it in 2 quarters. The position peaked at $1.08K in Q4 2022. 18 funds tracked by Wall St. Rank hold COEPW as of Q1 2023.

  • Steve Schonfeld reported no remaining Coeptis Therapeutics Warrants position as of Q1 2023 after selling out during the quarter.
  • Steve Schonfeld sold 10,806 Coeptis Therapeutics Warrants shares in Q1 2023, an estimated $1.08K.
  • Steve Schonfeld first reported a position in Coeptis Therapeutics Warrants in Q2 2022 and held it in 2 quarters.
  • Steve Schonfeld's Coeptis Therapeutics Warrants position peaked at $1.08K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.